IMMUNOPHARMA CONSULTING LTD
Company number 06617668 · Monitor this company
Net assets, total assets & total liabilities 2016 – 2025
- Total liabilities
Figures extracted from filed accounts. Hover a point for the exact value.
Balance sheet by year 10 years
Latest accounts (2025-08-31): Audit exempt (accountant's report).
| Year ending | Total assets | Total liabilities | Net assets | Cash | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 2025-08-31 | — | -£744 | — | £87,484 | — | — | 0 |
| 2024-08-31 | — | -£36,394 | — | £124,231 | — | — | |
| 2023-08-31 | — | -£32,207 | — | £110,933 | — | — | |
| 2022-08-31 | — | -£28,066 | — | £97,204 | — | — | |
| 2021-08-31 | — | -£7,118 | — | £9,185 | — | — | |
| 2020-08-31 | — | -£7,681 | — | £6,869 | — | — | |
| 2019-08-31 | — | -£6,580 | — | £6,888 | — | — | |
| 2018-08-31 | — | -£5,369 | — | £2,351 | — | — | |
| 2017-08-31 | — | -£4,323 | — | £2,790 | — | — | |
| 2016-08-31 | — | -£3,291 | — | £3,324 | — | — |
Profit and employee figures are captured from accounts filed from August 2026 onwards, where the accounts disclose them.